Titrimetric determinations

Quantitative analysis on known species or compounds in solutions as assay determination or impurity determination

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Ph. Eur. methods: 2.2.19, 2.2.20, 2.5.1, 2.5.2, 2.5.3, 2.5.4, 2.5.5, 2.5.6, 2.5.11, 2.5.29, 2.5.30, USP-NF method <541>, 2.5.7, 2.5.36